BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 5,280.00
-20.00 (-0.38%)
At close: Jul 21, 2025, 3:30 PM KST
BioNote Revenue
BioNote had revenue of 28.45B KRW in the quarter ending March 31, 2025, with 12.39% growth. This brings the company's revenue in the last twelve months to 105.92B, up 12.42% year-over-year. In the year 2024, BioNote had annual revenue of 102.78B with 14.10% growth.
Revenue (ttm)
105.92B
Revenue Growth
+12.42%
P/S Ratio
5.05
Revenue / Employee
355.43M
Employees
298
Market Cap
535.19B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| HLB Co., Ltd. | 74.64B |
| Peptron | 4.30B |
| PharmaResearch | 392.31B |